Pretreatment with Antibiotics Impairs Th17-Mediated Antifungal Immunity in Newborn Rats

Ping Wang1, Jie Yao2, Li Deng2

  • 1Department of Neonatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. wangping486@126.com.

Inflammation
|July 6, 2020
PubMed

Insights

Antibiotic use in newborns impairs the immune system, increasing fungal infection risk. This study shows antibiotics harm infant immunity, suggesting a need for antifungal prophylaxis in high-risk preterm babies.

Area of Science:

  • Neonatal immunology
  • Infectious diseases
  • Microbiology

Background:

  • Antibiotics, particularly carbapenems, are linked to fungal infections in preterm infants.
  • The exact cause of increased fungal risk (infant immunity vs. antibiotic effects) remains unclear.

Purpose of the Study:

  • To investigate the impact of antibiotic exposure on neonatal antifungal immunity.
  • To elucidate the mechanisms by which antibiotics increase susceptibility to fungal infections.

Main Methods:

  • Newborn rats were administered antibiotics and compared to untreated controls.
  • Immune response, fungal load (beta-glucan levels), and tissue pathology were assessed.
  • Key immune pathways, including TLR2, IL-17A, and neutrophil recruitment, were analyzed.

Main Results:

  • Antibiotic-treated rats showed impaired anti-Candida albicans immunity.
  • Increased fungal beta-glucan levels, abdominal fungal infections, and intestinal damage were observed.
  • Antibiotics reduced TLR2-mediated innate immunity, IL-17A release, and neutrophil recruitment.

Conclusions:

  • Antibiotic administration in neonates significantly weakens antifungal immunity.
  • This impairment increases susceptibility to fungal infections.
  • Antifungal prophylaxis may be necessary for high-risk preterm infants post-antibiotic therapy.